Twenty-Second versus Sixty-Second Dilation Duration in Endoscopic Papillary Balloon Dilation for the Treatment of Small Common Bile Duct Stones: A Prospective Randomized Controlled Multicenter Trial
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Bang, Byoung Wook | - |
dc.contributor.author | Lee, Tae Hoon | - |
dc.contributor.author | Song, Tae Jun | - |
dc.contributor.author | Han, Joung-Ho | - |
dc.contributor.author | Choi, Hyun Jong | - |
dc.contributor.author | Moon, Jong Ho | - |
dc.contributor.author | Kwon, Chang-Il | - |
dc.contributor.author | Jeong, Seok | - |
dc.date.accessioned | 2021-08-11T20:47:02Z | - |
dc.date.available | 2021-08-11T20:47:02Z | - |
dc.date.issued | 2015-01 | - |
dc.identifier.issn | 2234-2400 | - |
dc.identifier.issn | 2234-2443 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/11029 | - |
dc.description.abstract | Background/Aims: Endoscopic papillary balloon dilation (EPBD) has been advocated as an alternative therapy to endoscopic sphincterotomy for the treatment of common bile duct (CBD) stones. However, there is no established consensus on the optimal balloon dilation duration (BDD). We prospectively evaluated the efficacy and post-endoscopic retrograde cholangiopancreatography (ERCP) complications between the 20-and 60-second EPBD groups. Methods: A total of 228 patients with small CBD stones (=12 mm) were randomly assigned to undergo EPBD with a 20-or 60-second duration at six institutions. We evaluated baseline patient characteristics, endoscopic data, clinical outcomes, and procedure-related complications. In addition, we analyzed risk factors for postprocedural pancreatitis. Results: CBD stones were removed successfully in 107 of 109 patients (98.1%) in the 20-second group and in 112 of 119 patients (94.1%) in the 60-second group (p=0.146). Post-ERCP pancreatitis developed in seven patients (6.4%) in the 20-second group and nine patients (7.5%) in the 60-second group (p=0.408). In multivariate analysis, contrast dye injection into the pancreatic duct is a significant risk factor for post-EPBD pancreatitis. Conclusions: Based on the data showing that there were no significant differences in safety and efficacy between the two BDD groups, 20 seconds of BDD may be adequate for treatment of small CBD stones with EPBD. | - |
dc.format.extent | 7 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | 대한소화기내시경학회 | - |
dc.title | Twenty-Second versus Sixty-Second Dilation Duration in Endoscopic Papillary Balloon Dilation for the Treatment of Small Common Bile Duct Stones: A Prospective Randomized Controlled Multicenter Trial | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.5946/ce.2015.48.1.59 | - |
dc.identifier.scopusid | 2-s2.0-84961287897 | - |
dc.identifier.wosid | 000410060300012 | - |
dc.identifier.bibliographicCitation | Clinical Endoscopy, v.48, no.1, pp 59 - 65 | - |
dc.citation.title | Clinical Endoscopy | - |
dc.citation.volume | 48 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 59 | - |
dc.citation.endPage | 65 | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001959287 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Gastroenterology & Hepatology | - |
dc.relation.journalWebOfScienceCategory | Gastroenterology & Hepatology | - |
dc.subject.keywordAuthor | Cholangiopancreatography | - |
dc.subject.keywordAuthor | Endoscopic retrograde | - |
dc.subject.keywordAuthor | Choledocholithiasis | - |
dc.subject.keywordAuthor | Pancreatitis | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.